Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Advanced Metastatic Breast Cancer × Goserelin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 41 Breast Neoplasms 31 Breast Neoplasms, Male 3 Neoplasm Metastasis 2 Infertility 2 Advanced Breast Cancer 2 Sexual Dysfunction, Physiological 1 Recurrence 1 Prostate Adenocarcinoma 1 Primary Ovarian Insufficiency 1 Osteoporosis 1 Osteitis Deformans 1 Neoplasms 1 Leiomyoma 1 Hot Flashes 1 Hemorrhage 1 Breast Cancer Invasive 1 Anemia 1 Advanced Prostate Cancer 1 Advanced Metastatic Breast Cancer 1

Interventions

ribociclib 1 Tamoxifen 1 Letrozole 1 Goserelin 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02278120 2024-03-12

MONALEESA-7

Novartis

Phase 3 Completed

672 enrolled 16 charts 1 FDA

Advanced Metastatic Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡